Calvin Sandra sold TVTX
December 24, 2025 · Form 4 insider transaction
Calvin Sandra sold 7,402 shares of Travere Therapeutics, Inc. at $40.00 per share, a transaction worth $296.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
7,402
Price
$40.00
Total value
$296.1K
InsiderCalvin Sandra
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 24, 2025
Filing dateDecember 29, 2025
Shares owned after38,233
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on June 10, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.